COVID-19 myocarditis and prospective heart failure burden
Anastasia Shchendrygina, Eike Nagel, Valentina O. Püntmann, Silvia Valbuena-López
Abstract
: COVID-19 is an emerging threat for the heart. The extent of CV injury, along with the short and long-term sequelae, requires further investigation. The early detection of residual myocardial changes in COVID-19 survivors is of utmost importance in order to identify those patients at risk of CV complication development.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)MyocarditisHeart failureIntensive care medicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCardiologyInternal medicineProspective cohort studyDiseaseVirologyOutbreakInfectious disease (medical specialty)Viral Infections and Immunology ResearchCardiovascular Function and Risk FactorsCardiac electrophysiology and arrhythmias